BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32124242)

  • 21. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma.
    van de Nes JA; Nelles J; Kreis S; Metz CH; Hager T; Lohmann DR; Zeschnigk M
    Am J Surg Pathol; 2016 Jun; 40(6):796-805. PubMed ID: 27015033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAP1 regulates cell cycle progression through E2F1 target genes and mediates transcriptional silencing via H2A monoubiquitination in uveal melanoma cells.
    Pan H; Jia R; Zhang L; Xu S; Wu Q; Song X; Zhang H; Ge S; Xu XL; Fan X
    Int J Biochem Cell Biol; 2015 Mar; 60():176-84. PubMed ID: 25582751
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
    Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
    Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumours associated with BAP1 mutations.
    Murali R; Wiesner T; Scolyer RA
    Pathology; 2013 Feb; 45(2):116-26. PubMed ID: 23277170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
    Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
    J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
    Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
    Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma.
    Smit KN; van Poppelen NM; Vaarwater J; Verdijk R; van Marion R; Kalirai H; Coupland SE; Thornton S; Farquhar N; Dubbink HJ; Paridaens D; de Klein A; Kiliç E
    Mod Pathol; 2018 May; 31(5):763-771. PubMed ID: 29327717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic impact of HERC2 protein and pink-eyed dilution protein in uveal melanoma.
    Kashyap S; Singh MK; Jha J; Singh L; Pushker N; Sen S; Venkatesh P; Meel R; Lomi N
    Hum Cell; 2020 Oct; 33(4):1264-1272. PubMed ID: 32686068
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline large deletion of BAP1 and decreased expression in non-tumor choroid in uveal melanoma patients with high risk for inherited cancer.
    Boru G; Grosel TW; Pilarski R; Stautberg M; Massengill JB; Jeter J; Singh A; Marino MJ; McElroy JP; Davidorf FH; Cebulla CM; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2019 Sep; 58(9):650-656. PubMed ID: 30883995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.
    Pan H; Lu L; Cui J; Yang Y; Wang Z; Fan X
    Aging (Albany NY); 2020 Jan; 12(2):1446-1464. PubMed ID: 31954372
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma.
    Song H; Wang L; Lyu J; Wu Y; Guo W; Ren G
    Oncotarget; 2017 Apr; 8(17):29080-29090. PubMed ID: 28404968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutation in the TP53 gene in uveal melanoma.
    Hajkova N; Hojny J; Nemejcova K; Dundr P; Ulrych J; Jirsova K; Glezgova J; Ticha I
    Sci Rep; 2018 May; 8(1):7618. PubMed ID: 29769598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BAP1 regulates epigenetic switch from pluripotency to differentiation in developmental lineages giving rise to BAP1-mutant cancers.
    Kuznetsov JN; Aguero TH; Owens DA; Kurtenbach S; Field MG; Durante MA; Rodriguez DA; King ML; Harbour JW
    Sci Adv; 2019 Sep; 5(9):eaax1738. PubMed ID: 31555735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline BAP1 alterations in familial uveal melanoma.
    Rai K; Pilarski R; Boru G; Rehman M; Saqr AH; Massengill JB; Singh A; Marino MJ; Davidorf FH; Cebulla CM; H Abdel-Rahman M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):168-174. PubMed ID: 27718540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress.
    Chua V; Lopez-Anton M; Mizue Terai ; Ryota Tanaka ; Baqai U; Purwin TJ; Haj JI; Waltrich FJ; Trachtenberg I; Luo K; Tudi R; Jeon A; Han A; Chervoneva I; Davies MA; Aguirre-Ghiso JA; Sato T; Aplin AE
    Sci Signal; 2024 Jun; 17(840):eadn8376. PubMed ID: 38861613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does NEMO/IKKγ protein have a role in determining prognostic significance in uveal melanoma?
    Singh MK; Pushker N; Meel R; Chodsol K; Sen S; Bakhshi S; Singh L; Kashyap S
    Clin Transl Oncol; 2018 Dec; 20(12):1592-1603. PubMed ID: 29796997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
    Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
    Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.